print
mail
Home
Media
Featured Content
Update to U.S. Prescribing Information for Aranesp® and EPOGEN®
Overview
Fact Sheets
Featured Content
Press Releases
Media Contacts
In the News
Virtual Press Kits
Update to U.S. Prescribing Information for Aranesp® and EPOGEN®
Amgen is committed to the highest standards of patient safety.
Amgen Announces Update to U.S. Prescribing Information for Aranesp® (darbepoetin alfa) and EPOGEN® (Epoetin alfa)
Amgen’s Statement on Safety of Aranesp® (darbepoetin alfa) and EPOGEN® (Epoetin alfa)
UPDATED:
Letter to Healthcare Professionals
UPDATED:
Prescribing information for Aranesp® (darbepoetin alfa)
UPDATED:
Prescribing information for EPOGEN® (Epoetin alfa)
footer